Validation of the definition of rheumatoid arthritis flare based on SDAI and CDAI in clinical practice in two French independent cohorts

Ann Rheum Dis. 2024 Apr 11;83(5):679-680. doi: 10.1136/ard-2023-225272.

Authors

Jérôme Avouac¹, Sophie Hecquet², Marion Thomas², Alice Combier², Sandrine Carvès², Yannick Allanore²

Affiliations

¹ Service de Rhumatologie, Hôpital Cochin, AP-HP. Centre - Université Paris Cité, Paris, Île-de-France, France [email protected].
² Service de Rhumatologie, Hôpital Cochin, AP-HP. Centre - Université Paris Cité, Paris, Île-de-France, France.

PMID: 38182403
DOI: 10.1136/ard-2023-225272

No abstract available

Keywords: Patient Reported Outcome Measures; Rheumatoid Arthritis; Sensitivity and Specificity.

Publication types

Letter

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Humans
Remission Induction
Severity of Illness Index

Substances

Antirheumatic Agents